Literature DB >> 16442376

Acute predictors of subacute complete heart block after alcohol septal ablation for obstructive hypertrophic cardiomyopathy.

Annabel A Chen1, Igor F Palacios, Theofanie Mela, Danita M Yoerger, Michael H Picard, Gus Vlahakes, Patricia A Lowry, Michael A Fifer.   

Abstract

Acute and subacute complete heart block (CHB) are sequelae of alcohol septal ablation (ASA) for obstructive hypertrophic cardiomyopathy. Temporary pacemakers are routinely placed at the time of ASA, but there are no widely accepted guidelines for their management. This study examined acute predictors of subacute CHB in 52 consecutive ASA procedures in 48 patients without preexisting permanent pacemakers. Acute CHB occurred during 32 ASA procedures (62%), with the return of atrioventricular conduction on the day of ASA in all cases. New intraventricular conduction defects (IVCDs) were noted after 32 procedures (62%); in 9 of these, there was new first-degree atrioventricular block as well. CHB recurred subacutely 36 +/- 22 hours after 13 ASA procedures (25%). In 5 of these cases, there was absent or inconsistent ventricular escape rhythm. Subacute CHB did not occur in 9 cases without acute CHB during ASA or new IVCDs after ASA. Acute CHB during ASA, new IVCDs after ASA, and new first-degree atrioventricular block after ASA incrementally increased the risk for subacute CHB. In conclusion, patients with acute CHB during ASA or new IVCDs after ASA are at high risk for developing subacute CHB, sometimes without a reliable escape rhythm; these patients should therefore have temporary pacing support for > or = 48 hours after ASA or the last occurrence of CHB. Patients without acute CHB during ASA or new IVCDs after ASA are at low risk for subacute CHB.

Entities:  

Mesh:

Year:  2005        PMID: 16442376     DOI: 10.1016/j.amjcard.2005.08.032

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

Review 1.  Contemporary Therapies and Future Directions in the Management of Hypertrophic Cardiomyopathy.

Authors:  Elizabeth Packard; Alejandro de Feria; Supriya Peshin; Nosheen Reza; Anjali Tiku Owens
Journal:  Cardiol Ther       Date:  2022-10-15

Review 2.  The "1st septal unit" in hypertrophic obstructive cardiomyopathy: a newly recognized anatomo-functional entity, identified during recent alcohol septal ablation experience.

Authors:  Paolo Angelini
Journal:  Tex Heart Inst J       Date:  2007

3.  Medical, surgical and interventional management of hypertrophic cardiomyopathy with obstruction.

Authors:  Sammy Elmariah; Michael A Fifer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-12

4.  Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation.

Authors:  Qiulan Yang; Changsheng Zhu; Hao Cui; Bing Tang; Shengwei Wang; Qinjun Yu; Shihua Zhao; Yunhu Song; Shuiyun Wang
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 2.895

5.  Microsphere embolisation as an alternative for alcohol in percutaneous transluminal septal myocardial ablation.

Authors:  P A Vriesendorp; N M Van Mieghem; W B Vletter; F J Ten Cate; P L de Jong; A F L Schinkel; M Michels
Journal:  Neth Heart J       Date:  2013-05       Impact factor: 2.380

Review 6.  Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: From Experiment to Standard of Care.

Authors:  Lothar Faber
Journal:  Adv Med       Date:  2014-05-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.